Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study Publisher Pubmed



Rizi ZS1 ; Shams L1, 2 ; Rad FR1 ; Zamani M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Source: Journal of Molecular Neuroscience Published:2024


Abstract

Alzheimer’s disease is a neurodegenerative disorder with polygenic etiology. Genetic risk variants for Alzheimer’s disease differ among populations. Thus, discovering them in each population is clinically important. A total of 118 patients and 97 controls for VDR rs11568820 and 88 patients and 100 healthy controls for MTHFR C677T polymorphism were genotyped to evaluate the association of these polymorphisms with late-onset Alzheimer’s disease in the Iranian population, along with their impacts on the response to Rivastigmine treatment. The VDR C allele was significantly associated with Alzheimer’s disease and provided protection against it (P = 0.003, RR = 1.14, 95% CI 1.04–1.24), while the T allele increased susceptibility (P = 0.003, RR = 1.93, 95% CI 1.23–3.02). These results were also considerable upon excluding the effect of APOE ε4 allele. The Prevalence-corrected Positive Predictive Value was 1.71% for the VDR CC genotype and 4% for the VDR CT genotype, indicating lower and almost twofold higher chances of developing Alzheimer’s disease, respectively. No significant correlation was observed between MTHFR C677T and Alzheimer’s disease. Based on our pharmacogenetic study, MTHFR T allele carriers lacking APOE ε4 allele showed a better response to Rivastigmine treatment after a 2-year follow-up. Moreover, patients with VDR CC genotype displayed milder Alzheimer’s disease, particularly when coincided with the APOE ε4 allele. The VDR rs11568820 polymorphism affects both Alzheimer’s disease risk and the response to Rivastigmine in Iranian patients. Also, MTHFR C677T polymorphism may play a role in the response to Rivastigmine, through a pathway that needs to be elucidated in future studies. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.